The pharmaceutical company once led by Martin Shkreli has officially imploded. In a filing with the SEC on Wednesday, KaloBios announced that its interim CFO and auditor both resigned, leaving the company with limited executive leadership. Additionally, the Nasdaq informed KaloBios that its stock would be delisted. Shares of the company had been halted since Shkreli's December 17 arrest on securities-fraud charges. Shkreli was fired as CEO of KaloBios on December 17.
Read the rest of the story HERE:
Sheila Samples is an Oklahoma writer and a former civilian US Army Public Information Officer. She is a Managing Editor for OpEd News, and a regular contributor for a variety of Internet sites.